Surendra Shenoy, MD-PhD said, "The Amplifi System is the first device that has real potential to address both of these challenges in a major way, to make good on the promise of providing reliable, long-lasting vascular access sites for this unique and vulnerable patient population."
This stock-for-stock merger transaction in which Flow Forward Medical merged with and into Artio was approved by the Board of Directors and stockholders of both companies. The transaction closed on June 8, 2020.
The interim data demonstrated that use of the Endura™ Embolization System in bifurcation aneurysms can result in greater aneurysm occlusion and lower coil prolapse into parent arteries when compared to commercially available coil-only treatments.
Metactive also announced the closing of $1.5 million of additional Series A financing, co-led by Mid-America Angels, with the participation of a family office and additional individual investors. Metactive previously raised $7.5 million in Series A funding, bringing the total funding raised to $9 million.
Medical Device News Magazine keeps our readers up-to-date on breaking medical device industry news and more!